Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population?
- PMID: 19358908
- PMCID: PMC2801433
- DOI: 10.1016/j.ocl.2009.01.004
Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population?
Abstract
The relationship between corticosteroids and osteonecrosis is well known. Limited data suggest that statins modulate cholesterol metabolism and may protect against osteonecrosis. The authors analyzed their prospective renal transplant database to determine if statin usage reduces the incidence of corticosteroid-related osteonecrosis and identified 2,881 renal transplantation patients who met the entry criteria. Among 338 patients on statins, 15 (4.4%) developed osteonecrosis, versus 180 of 2,543 (7%) patients who were not on statins. Osteonecrosis-free survival was similar in patients with and without statin exposure.
Figures
References
-
- Harrington KD, Murray WR, Kountz SL, Belzer FO. Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am. 1971 Mar;53(2):203–215. - PubMed
-
- Ibels LS, Alfrey AC, Huffer WE, Weil R., 3rd Aseptic necrosis of bone following renal transplantation: experience in 194 transplant recipients and review of the literature. Medicine (Baltimore) 1978 Jan;57(1):25–45. - PubMed
-
- Julian BA, Quarles LD, Niemann KM. Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis. 1992 Feb;19(2):99–120. - PubMed
-
- Carvalho AC, Lees RS, Vaillancourt RA, Cabral RB, Weinberg RM, Colman RW. Intravascular coagulation in hyperlipidemia. Thromb Res. 1976 Jun;8(6):843–857. - PubMed
-
- Jones JP., Jr Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop Relat Res. 1993 Jul;(292):294–308. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
